Shoreline Biosciences Names Chief Business Officer

San Diego-based biotechnology company Shoreline Biosciences said this morning that it has named Scott Forrest, Ph.D., as its Chief Business Officer. Forrest was most recently Chief Financial Officer at Autobahn Therapeutics, and also served at Inception Therapeutics, the Versant Ventures company building biotech companies. He also previously served at such companies at Lycia Therapeutics, Pipeline Therapeutics, Chinook Therapeutics and Ventus Therapeutics, among many others. Shoreline says it is developing allogeneic off-the-shelf, standardized, and targeted induced pluripotent stem cells (iPSC) derived natural killer (NK) and Macrophage cellular immunotherapies.